← Eichor
Study identifier: NCT06179459 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections

Condition: Acute Pancreatitis · Pancreatic Pseudocyst · Pancreatic Necrosis  ·  Sponsor: Orlando Health, Inc.

PhaseN/A
Planned participants110
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Acute pancreatitis is one of the most common gastrointestinal disorders requiring hospitalization worldwide. Pancreatic fluid collections can occur as a consequence of acute and chronic pancreatitis and can result in significant morbidity and mortality, including significant abdominal pain, gastric outlet obstruction, biliary obstruction, organ failure, persistent unwellness, infection and sepsis. Symptomatic pancreatic fluid collections require treatment, and endoscopic drainage is considered standard of care. The aim of this study is to evaluate the treatment outcomes in patients undergoing standard of care, endoscopic treatment of pancreatic fluid collections.

This description comes directly from the study's public registry record.

Talk to the study team

Ji Young Bang  ·  321-841-2431  ·  jiyoung.bang@orlandohealth.com

Barbara J Broome  ·  321-841-4356  ·  barbara.broome@orlandohealth.com

Always discuss trial participation with your own doctor first.

Locations (1)

Orlando HealthOrlando, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06179459